On February 8, 2019 a meeting was held at the Enterprise on the basis of a round table with the participation of representatives of Rospatent, the Federal Antimonopoly Service and Russian pharmaceutical manufacturers at the initiative of the Ministry of Industry and Trade of Russia.
The focus was on topical issues of the protection and use of intellectual property in the pharmaceutical field, as well as the problem of combat with "evergreen patents"
The issues of granting of a compulsory license were discussed, as well as the topic of creation of a Unified Register of pharmacologically active compounds.
The discussion was attended by thee First Deputy Minister of Industry and Trade of the Russian Federation Sergey Anatolyevich Tsyb, the Deputy Head of Rospatent Lyubov Leonidovna Kiriy, the Co-Chairman of the All-Russian Public Organization "Business Russia" Alexey Repik, the representatives of pharmaceutical companies.
The experts from industry departments of the Federal Institute of Industrial Property (FIPS) highlighted approaches to the examination of applications for inventions and utility models, as well as the nuances of assessment of the patentability of new modifications of known inventions.
Comment type is not specified in the component properties.